Nektar Therapeutics | NKTR - Assets

Nektar Therapeutics reported $710.6M in Assets for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Assets Change
Agios Pharmaceuticals AGIO:US USD 1.24B 58.4M
ALKERMES ALKS:US USD 1.96B 22.08M
Amgen AMGN:US USD 65.12B 1.42B
Astrazeneca AZN:US USD 96.48B 2.3B
Baxter International BAX:US USD 28.29B 322M
Biocryst Pharmaceuticals BCRX:US USD 550M 8.59M
Biogen BIIB:US USD 24.55B 300.1M
Bluebird Bio BLUE:US USD 520.1M 53.49M
Cara Therapeutics CARA:US USD 182.24M 31.27M
Eisai 4523:JP JPY 1.25T 10.21B
Esperion Therapeutics ESPR:US USD 247.94M 64.89M
Exelixis EXEL:US USD 3.07B 110.12M
Gilead Sciences GILD:US USD 63.17B 614M
GlaxoSmithKline GSK:LN GBP 60.15B 167M
Halozyme Therapeutics HALO:US USD 1.84B 23.03M
Immunogen IMGN:US USD 348.94M 9.86M
IONIS PHARMACEUT IONS:US USD 2.53B 111.9M
Ironwood Pharmaceuticals IRWD:US USD 1.1B 60.18M
Karyopharm Therapeutics KPTI:US USD 358.17M 126.94M
Macrogenics MGNX:US USD 280.47M 85.12M
Mirati Therapeutics MRTX:US USD 1.2B 100.44M
Nektar Therapeutics NKTR:US USD 710.6M 70.41M
Neurocrine Biosciences NBIX:US USD 2.37B 225.3M
Novartis NOVN:VX USD 117.45B 1.01B
Roche Holding ROG:VX 88.15B 1.42B
Sarepta Therapeutics SRPT:US USD 3.13B 27.78M
Seattle Genetics SGEN:US USD 3.67B 55.45M
Takeda 4502:JP JPY 13.5T 1.08T
Teva Pharmaceutical TEVA:IT USD 44.01B 246M
Xencor XNCR:US USD 846.27M 11M
YTE INCY:US USD 5.84B 330.77M